EUVIMEDEUVIMED entdecken
Crossref

Soy isoflavone ameliorates gut-brain axis dysfunction via ER-β activation and β-glucuronidase modulation in estrogen-deficient rats

Rishabh Chaudhary, Sowvik Bag, Nitin Bansal, Roshan Lal, Mahendra Bishnoi, Kanthi Kiran Kondepudi, Kanwaljit Chopra, Seema Bansal

European Journal of Pharmacology · 2026-01 · 1013 · 178503

DOI: 10.1016/j.ejphar.2025.178503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-01. Verfasst von Rishabh Chaudhary und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India. El…. Hauptthemen laut MEDLINE: Isoflavones, Estrogen Receptor beta, Glucuronidase, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Haryana State Council for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Gut-brain axis (GBA) plays a crucial role in neuroendocrine homeostasis, and its dysregulation due to estrogen deficiency is associated with cognitive decline, mood disorders, and gut microbiome disturbances in postmenopausal women. The gut microbiome involved in estrogen metabolism, known as the estrobolome, regulates β-glucuronidase activity, which influences estrogen reactivation and systemic availability. Reduced estrobolome function and altered β-glucuronidase activity in post-menopause may exacerbate GBA dysfunction. Thus, strategies that modulate the estrobolome and enhance β-glucuronidase may be beneficial in improving postmenopausal GBA dysfunction. With this background, our study aims to determine the effect of soy isoflavone (SIF) on GBA dysfunction in estrogen-deficient rats. To induce GBA dysfunction, rats were first bilaterally ovariectomized (OVX) and, after one week, treated with SIF (40 and 80 mg/kg)/17β-estradiol (17βE2) for 28 days. In OVX rats, one-month administration of SIF maintained estrogen receptor-β (ER-β) expression over estrogen receptor-α (ER-α), preserved gut eubiosis by modulating the estrobolome, increased β-glucuronidase enzyme and GUSB gene levels. Additionally, SIF also restores physiological and neurobehavioral parameters. In addition to this, SIF regulates mucosal integrity, tight junction genes, inflammatory markers, oxidative stress, monoamine neurotransmission, hypothalamic-pituitary axis regulations, and apoptosis. Comparative profiling of SIF with 17βE2 shows that 17βE2 improves gut and brain health, while preserving serum estradiol levels and uterine horn weight. This may enhance the feminizing side effects of 17βE2. However, SIF did not show any uterotrophic effect. SIF at doses of 40 and 80 mg/kg may offer a safer alternative to 17βE2 for managing GBA dysfunction in postmenopausal women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoflavonesEstrogen Receptor betaGlucuronidaseBrainEstrogensGlycine maxBrain-Gut AxisAnimalsFemaleRatsGastrointestinal MicrobiomeOvariectomyEstradiolRats, Sprague-Dawley

Stichwörter der Autor:innen

ERβGut microbiome/estrobolomeGut-brain axisPostmenopauseSoy isoflavoneβ-glucuronidase

Substanzen

IsoflavonesEstrogen Receptor betaGlucuronidaseEstrogensEstradiol

Autor:innen und Institutionen

  • Department of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India. Electronic address: rishabhchaudhary0001@gmail.com.
  • Department of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India. Electronic address: sowvikbag2@gmail.com.
  • Department of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani, Haryana, India. Electronic address: nitindsp@rediffmail.com.
  • Healthy Gut Research Group, Centre for Excellence in Functional Foods, Division of Food and Nutritional Biotechnology, National Agri-Food Biotechnology Institute (NABI), Knowledge City-Sector 81, SAS Nagar, Punjab, 1403…
  • Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. Electronic address: dr_chopra_k@yahoo.com.
  • Department of Pharmacology, M. M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, 133207, Haryana, India. Electronic address: 2006.seema@gmail.com.

Förderung

  • Haryana State Council for Science and Technology

Zitieren

APA

Chaudhary, R., Bag, S., Bansal, N., Lal, R., Bishnoi, M., Kondepudi, K. K., Chopra, K., & Bansal, S. (2026). Soy isoflavone ameliorates gut-brain axis dysfunction via ER-β activation and β-glucuronidase modulation in estrogen-deficient rats. European Journal of Pharmacology, 1013, 178503. https://doi.org/10.1016/j.ejphar.2025.178503

Vancouver

Chaudhary R, Bag S, Bansal N, Lal R, Bishnoi M, Kondepudi KK, et al. Soy isoflavone ameliorates gut-brain axis dysfunction via ER-β activation and β-glucuronidase modulation in estrogen-deficient rats. European Journal of Pharmacology. 2026;1013:178503. doi:10.1016/j.ejphar.2025.178503

BibTeX
@article{Chaudhary2026,
  author = {Chaudhary, Rishabh and Bag, Sowvik and Bansal, Nitin and Lal, Roshan and Bishnoi, Mahendra and Kondepudi, Kanthi Kiran and Chopra, Kanwaljit and Bansal, Seema},
  title = {Soy isoflavone ameliorates gut-brain axis dysfunction via ER-β activation and β-glucuronidase modulation in estrogen-deficient rats},
  journal = {European Journal of Pharmacology},
  year = {2026},
  volume = {1013},
  pages = {178503},
  doi = {10.1016/j.ejphar.2025.178503}
}
Kostenlos starten →